Menu

Filtros : "Inglaterra" "FM" "Vifor Pharma" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction (2022)

    Docherty, Kieran F; Ogunniyi, Modele O; Anand, Inder S; Desai, Akshay S; Diez, Mirta; Howlett, Jonathan G; Nicolau, Jose Carlos ; O'meara, Eileen; Verma, Subodh; Inzucchi, Silvio E

    Source: Jacc-heart failure. Unidade: FM

    Subjects: INSUFICIÊNCIA CARDÍACA, FÁRMACOS SINTÉTICOS, MORTALIDADE HOSPITALAR

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DOCHERTY, Kieran F et al. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, v. 10, n. 1, p. 52-64, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jchf.2021.08.006. Acesso em: 04 out. 2024.

    • APA

      Docherty, K. F., Ogunniyi, M. O., Anand, I. S., Desai, A. S., Diez, M., Howlett, J. G., et al. (2022). Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, 10( 1), 52-64. doi:10.1016/j.jchf.2021.08.006

    • NLM

      Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006

    • Vancouver

      Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2024 out. 04 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006

  • Artigo de periodico

    Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022)

    Butler, Javed ; Anker, Stefan D ; Lund, Lars H. ; Coats, Andrew J. S.; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; FRIEDE, Tim ; Fabien, Vincent ; Kosiborod, Mikhail; Metra, Marco

    Source: European heart journal. Unidade: FM

    Subjects: PLACEBOS, POTÁSSIO, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BUTLER, Javed et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, v. 43, n. 41, p. 4362-4373, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50465. Acesso em: 04 out. 2024.

    • APA

      Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G., Siddiqi, T. J., et al. (2022). Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, 43( 41), 4362-4373. doi:10.1093/eurheartj/ehac401

    • NLM

      Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465

    • Vancouver

      Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465

  • Artigo de periodico

    The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2021)

    Jankowska, Ewa A; Kirwan, Bridget-Anne; Kosiborod, Mikhail; Butler, Javed; Anker, Stefan D; Mcdonagh, Theresa; Dorobantu, Maria; Drozdz, Jaroslaw; Filippatos, Gerasimos; Nicolau, Jose Carlos

    Source: European heart journal. Unidade: FM

    Subjects: FERRO, INSUFICIÊNCIA CARDÍACA, FERRO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      JANKOWSKA, Ewa A et al. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, v. 42, n. 31, p. 3011-+, 2021Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab234. Acesso em: 04 out. 2024.

    • APA

      Jankowska, E. A., Kirwan, B. -A., Kosiborod, M., Butler, J., Anker, S. D., Mcdonagh, T., et al. (2021). The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, 42( 31), 3011-+. doi:10.1093/eurheartj/ehab234

    • NLM

      Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2024 out. 04 ] Available from: https://doi.org/10.1093/eurheartj/ehab234

    • Vancouver

      Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2024 out. 04 ] Available from: https://doi.org/10.1093/eurheartj/ehab234
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024